CN106605908A - Fully nutritional formula product with special medical purposes for liver diseases - Google Patents
Fully nutritional formula product with special medical purposes for liver diseases Download PDFInfo
- Publication number
- CN106605908A CN106605908A CN201610371259.6A CN201610371259A CN106605908A CN 106605908 A CN106605908 A CN 106605908A CN 201610371259 A CN201610371259 A CN 201610371259A CN 106605908 A CN106605908 A CN 106605908A
- Authority
- CN
- China
- Prior art keywords
- fructus
- semen
- hepatopathy
- vitamin
- special
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019423 liver disease Diseases 0.000 title claims abstract description 45
- 235000016709 nutrition Nutrition 0.000 title abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- 235000018102 proteins Nutrition 0.000 claims abstract description 7
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 6
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 3
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 27
- 235000019197 fats Nutrition 0.000 claims description 11
- 108010073771 Soybean Proteins Proteins 0.000 claims description 10
- 235000019710 soybean protein Nutrition 0.000 claims description 10
- 240000000599 Lentinula edodes Species 0.000 claims description 9
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 9
- 235000008216 herbs Nutrition 0.000 claims description 9
- 230000010354 integration Effects 0.000 claims description 9
- -1 lactoprotein Proteins 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 6
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 229920000294 Resistant starch Polymers 0.000 claims description 5
- 235000021254 resistant starch Nutrition 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 241000229143 Hippophae Species 0.000 claims description 3
- 235000003935 Hippophae Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 229960003136 leucine Drugs 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 239000002366 mineral element Substances 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 235000019737 Animal fat Nutrition 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 2
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 241000220261 Sinapis Species 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 108010052008 colla corii asini Proteins 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000004576 sand Substances 0.000 claims description 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- 244000018436 Coriandrum sativum Species 0.000 claims 1
- 235000002787 Coriandrum sativum Nutrition 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000009609 fructus phyllanthi Substances 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 abstract description 9
- 244000179886 Moringa oleifera Species 0.000 abstract description 7
- 235000011347 Moringa oleifera Nutrition 0.000 abstract description 7
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 208000002720 Malnutrition Diseases 0.000 abstract description 5
- 230000001071 malnutrition Effects 0.000 abstract description 5
- 235000000824 malnutrition Nutrition 0.000 abstract description 5
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000002503 metabolic effect Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 210000005229 liver cell Anatomy 0.000 abstract 2
- 239000003925 fat Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 210000003494 hepatocyte Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 108010058846 Ovalbumin Proteins 0.000 description 4
- 240000005373 Panax quinquefolius Species 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 101710176384 Peptide 1 Proteins 0.000 description 2
- 206010067268 Post procedural infection Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a fully nutritional formula product with special medical purposes for liver diseases. The fully nutritional formula product is characterized by comprising the following materials in proportions: pre-digested carbohydrates, compound proteins, compound fats, medicinally and edibly homologous biological resources, dietary fibers, mineral premixes, vitamin premixes, moringa oleifera powder, cyclic adenosine monophosphate, etc. The product combines the metabolic characteristics and the nutritional requirements of patients with the liver diseases, and specially the medicinally and edibly homologous biological resource ingredients beneficial to the patients with the liver diseases are added. The product can improve the malnutrition status of the patients with the liver diseases, protects liver cells and promotes the repair and regeneration of the liver cells. Besides, the product is good in palatability, convenient for combination and uses, and easy for the patients with the liver disease to accept.
Description
Technical field
The present invention relates to a kind of special medicine purposes formula wholefood, particularly a kind of for hepatopath's
Specific full nutritional formulas.
Background technology
Liver is digestive gland maximum in human body, is the central station of substance in vivo energy metabolism.According to estimates, send out in liver
Raw chemical reaction has more than 500 kinds.First its secretion of bile, helps digest diet；It is the Amino acid synthesis albumen for absorbing
Matter supplies our human body energies, and let us can lustily complete darg；It can preserve and burn internal fat
Fat, controls our bodily form；It is the depot organ of fatsoluble vitamin；It can also aoxidize, reduce, decomposing internal poison
Element, swallows the antibacterial in imprudence wedging body, is the maximum removing toxic substances organ of human body.It is demonstrated experimentally that animal is extracing completely liver
Even if giving corresponding treatment afterwards, at most also can only survive more than 50 hour, and this explanation liver is of the activity of sustaining life
Requisite vitals.
At present, due to living habit, environmental pollution etc. factor, common hepatopathy is caused to have hepatitis, liver cirrhosis, liver pus
Swollen, primary hepatocarcinoma etc., hepatitis mainly based on chronic hepatitiss, by etiology chronic viral hepatitises, autoimmunity is divided into
The not clear chronic hepatitiss of hepatitis, drug toxicity hepatitis, hereditary and other reasons.
In the treatment and follow-up rehabilitation course of above-mentioned hepatopathy, reasonable diet is often referred to as hepatopath's treatment and health
Important ingredient in the multiple stage, therefore should be hepatopath and prepare some appetite strengthening, be conducive to the state of an illness to recover, nutrition is proper
When food.But now with product in, even if being claimed as the nutriment to hepatopath, it can be hepatopathy to be often also only
The food of patients is only capable of the health product for playing a role in health care, actually for, such product cannot be played completely
The effect of the curative nutritional supplementation before the immunotherapy targeted autoantibody and treatment to hepatopath or after treatment.
So, specific full nutritional formulas, i.e., one kind can meet target group in specific disease as single source of nutrition
The research and development of the special medicine purposes formula food of nutritional need are extremely urgent under disease or medical condition.
The content of the invention
The present invention combines traditional theory of Chinese medical science with practice, substantial amounts of has to hepatopath by being added in the formulation
The integration of edible and medicinal herbs living resources composition of benefit, and the material that curative effect is promoted with other auxiliary treatments or auxiliary is helped, it is prepared for having and controls
Therapeutic effect, it is nutritious comprehensively, the intestinal suitability it is good, easily by body digestion, absorb, and can fully meet hepatopath and use
, the formulation product with the special full nutrition for needing medical usage.
A kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, it is characterised in that by following
The material of mass percent is prepared from：
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned predigestion carbohydrate is through expanded, enzymolysis processing rice meal, Semen Maydis powder, oatmeal, little
One or more in flour, maltodextrin.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., one or more of above-mentioned compound protein in vegetable protein or animal proteinum；Preferably, it is above-mentioned compound
Albumen is by soybean protein, lactoprotein, soybean protein peptide, lact albumin hydrolysate, collagen peptide, ovalbumin peptide, Colla Corii Asini, side chain ammonia
One or more compositions in base acid, glutamine.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned branched-chain amino acid is by one or more side chains for constituting in leucine, isoleucine and L-Valine
Aminoacid.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., one or more of above-mentioned compound fat in plant fat or Animal fat；
Above-mentioned compound fat preferably be selected from Fructus Maydis oil, Oleum Camelliae, Oleum Arachidis hypogaeae semen, safflower oil, Oleum Brassicae campestriss, olive oil, butter oil,
One or more in soybean oil, medium-chain fatty acid and omega-fatty acid.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned dietary fiber refers to one or more in resistant starch, resistant dextrin, oligochitosan, oligofructose.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned integration of edible and medicinal herbs living resources refer to Poria, Rhizoma Polygonati, Pollen Pini, Lentinus Edodess, Radix Ginseng, Fructus Lycii, Rhizomadioscoreae, sand
Spine, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae, Fructus Crataegi, Herba portulacae, Radix Glycyrrhizae, the Radix Angelicae Dahuricae, Semen Ginkgo, Semen Lablab Album, Semen Cassiae, Bulbus Lilii, Semen Myristicae, Cortex Cinnamomi, emblic
Son, Semen Euryaless, Fructus Hordei Germinatus, Thallus Laminariae (Thallus Eckloniae), Fructus Momordicae, Semen Pruni, Flos Lonicerae, Fructus Canarii, Herba Houttuyniae, Semen Hoveniae (Fructus Hoveniae), Fructus Gardeniae, Fructus Amomi, Fructus Citri, perfume (or spice)
Ru, Semen Persicae, Fructus Alpiniae Oxyphyllae, Folium Nelumbinis, Semen Nelumbinis, Semen Sinapiss, Folium Perillae, Radix Puerariae, Herba Taraxaci, Semen Ziziphi Spinosae, Herba Menthae, Semen Coiciss, Fructus Rubi, Yuan
Sui, Flos Lonicerae, Folium Microcoris paniculatae, Spica Prunellae, Stigma Croci, Fructus Tsaoko, Rhizoma Kaempferiae etc. one or more；
Preferably, Poria, Rhizoma Polygonati, Pollen Pini, Lentinus Edodess, Radix Ginseng, Chinese holly must be included in above-mentioned integration of edible and medicinal herbs living resources
At least one component in Qi, Rhizomadioscoreae, Fructus Hippophae, Pericarpium Citri Reticulatae.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned mineral substance premix is selected from containing sodium, potassium, calcium, phosphorus, magnesium, ferrum, iodine, copper, zinc, manganese, selenium, molybdenum, chromium
In one or more mineral elements premix material.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., above-mentioned vitamin premix is selected from vitamin A, vitamin D, Vitamin E, vitamin K, vitamin B1, dimension
One kind in raw element B2, vitamin B6, Vitamin B12, vitamin C, nicotinic acid, Folic Acid, pantothenic acid, biotin, choline, taurine or
It is several.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., moringa powder refers to the powder of the extraction with leaf of Moringa and root as raw material.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, also with this
The characteristics of sample：I.e., cyclic adenosine monophosphate preferably is selected from the cyclic adenosine monophosphate extracted with Fructus Jujubae.
Further, a kind of hepatopathy that the present invention is provided needs the full age of medical usage with special, additionally provides
Following optimum ratios：I.e., it is prepared from by the material of following mass percent：
The effect of the present invention and effect：
The hepatopathy that the present invention is provided needs the full age of medical usage comprehensively, in time to provide hepatopathy trouble with special
Various nutrients and trace element needed for person, improve patient entirety nutriture, improve immunity of organisms, reduce postoperative infection and
While the generation of complication, moreover it is possible to protect hepatocyte, promote hepatocellular reparation and regeneration.
The product is rich in high-purity, high biological value compound protein, can be effectively improved negative nitrogen balance, effectively prevents low albumen
Mass formed by blood stasis and the multiple complications that produce.
Especially, in the product of the present invention, according to the cure mechanism of Chinese medicine, also added in a large number, such as：Poria, Huang
Essence, Pollen Pini, Lentinus Edodess, Radix Ginseng, Fructus Lycii, Rhizomadioscoreae, Fructus Hippophae, Pericarpium Citri Reticulatae etc. are beneficial to the integration of edible and medicinal herbs series matter of liver disease and recovery
Matter, while nutritional supplementation effect is played, moreover it is possible to protect the hepatocyte of patient, promotes the reparation and regeneration of wounded hepatocytes,
Beneficial patient recovers, and shortens length of stay, lowers medical expense.
Additionally, in the component of the present invention, having selected the component of multiple nutrition additions, each material fully melts during such component
While closing, promote, moreover it is possible to which difference is from different angles human body, particularly patient provides necessary nutritional supplementation.
Addition dietary fiber in the present invention：Dietary fiber is that health diet is indispensable, and fiber is keeping disappearing
Change and play important role on system health, while the enough fibers of intake can also prevention of liver disease, cardiovascular disease, cancer
Extraction and Other diseases in disease, diabetes, brain.In addition, fiber can clean wall of digestive and strengthen digestive function, fiber simultaneously can
Dilution and add carcinogen and noxious substance in food to remove, protect fragile digestive tract and prevent colon cancer.Fiber
Digestion rate and most rapid drainage cholesterol can also be slowed down, so the blood glucose that can be allowed in blood and cholesterol are controlled optimal
Level.But, because the component mostlys come from the cell wall of plant, comprising cellulose, hemicellulose, resin, pectin and wood
, there is the characteristics of being difficult by human consumption in the materials such as quality.So in the present invention, by adding integration of edible and medicinal herbs component, being combined
The components such as albumen, compound fat softening and assimilate dietary fiber so that it is more easy to be absorbed by human body.
Additionally, fat be the mankind meals in need ensure material.If it is not enough that human body takes in over a long time oils and fatss, in vivo
Long-term lacking fat, i.e., can malnutrition, muscle power is not good, lose weight, or even disability etc..
Additionally, leaf of Moringa can enhancing immunity, toxin expelling, body shaping, aging resistance, anticancer and to various chronic and major disease
Have while greatly improve effect, may further be used to treat the disease of the privileged sites such as liver, spleen, meridians, in the present invention
In, therapeutic effect of the product for hepatopathy is can further improve using the component, hepatocyte is protected, promote the regeneration of damaged cell
And repair function.
Additionally, cyclic adenosine monophosphate is the important substance of intracellular participation Auto-regulator metabolism and biological function, it is life
" second message,second messenger " of information transmission.Synthesis regulation to sugar, lipid metabolism, nucleic acid, protein etc. plays an important role.Therefore
And, while can improving product tolerance degree from the component in the present invention, can also improve stability between each component and
It is harmonious.
But, we often have found the certain monomer defect of the more or less presence of such component, thus are not suitable for list
One using.
Therefore, present invention employs, each component is carried out the cooperation and addition of designated ratio, always realizes eliminating each group
Divide the obstacle of itself, threpsology's balance of raising each component and the effective adjustment effect to human body.Each component is more merged, make
Effect of each component is maximized.
In addition, the product of present invention manufacture, due to using appropriate allotment ratio and allotment component, possessing product and using
Conveniently, the characteristics of dissolubility is good, sense of taste is good, it is easy to for patient's acceptance.
Therefore, product of the invention combines the metabolic characteristic and nutritional need of hepatopath, has been especially added with to hepatopathy
The compositions such as the integration of edible and medicinal herbs living resources of benefits subjects, can be effectively improved the malnutrition situation of hepatopath, protect hepatocyte,
Promote hepatocellular reparation and regeneration, and this product good palatability, configure and easy to use, it is easier to for hepatopath's acceptance.
Specific embodiment
In the following embodiments, compound vitamin be vitamin A, vitamin D, Vitamin E, vitamin K, vitamin B1,
One kind in vitamin B2, vitamin B6, Vitamin B12, vitamin C, nicotinic acid, Folic Acid, pantothenic acid, biotin, choline, taurine
Or the premix material of several vitamins；
Composite mineral matter is containing one or more in sodium, potassium, calcium, phosphorus, magnesium, ferrum, iodine, copper, zinc, manganese, selenium, molybdenum, chromium
The premix material of mineral element；
Such as it is mixture, the ratio of its each constituent can unrestricted choice according to demand.
The hepatopathy of embodiment 1 needs full age 1# of medical usage with special
| Supplementary material title | Ratio | Supplementary material title | Ratio |
| Maltodextrin | 23.5% | Oleum Brassicae campestriss | 3% |
| Enzymolysis rice flour | 15% | Oligofructose | 3% |
| Puffed oat powder | 7% | Resistant dextrin | 2% |
| Soybean protein isolate | 5% | Oligochitosan | 1% |
| Concentrated lactoalbumin | 8% | Rhizomadioscoreae | 1% |
| Collagen peptide | 2% | Poria | 1% |
| Whole milk powder | 3% | Lentinus Edodes extract | 1% |
| Arginine | 1.5% | Rhizoma Polygonati extract | 0.3% |
| Glutamine | 1.2% | Radix Ginseng extract | 0.3% |
| Branched-chain amino acid | 1% | Wolfberry fruit extract | 0.4% |
| Egg albumin polypeptide | 1% | Composite mineral matter | 2% |
| Medium-chain fatty acid | 7% | Compound vitamin | 0.8% |
| Omega-fatty acid | 2% | Cyclic adenosine monophosphate | 400ppm |
| Fructus Maydis oil | 7% |
Nutrient component meter
The hepatopathy of embodiment 2 needs full age 2# of medical usage with special
| Supplementary material title | Ratio | Supplementary material title | Ratio |
| Maltodextrin | 20.5% | Oligofructose | 2.5% |
| Enzymolysis rice flour | 13% | Resistant starch | 2.5% |
| Puffed oat powder | 3% | Oligochitosan | 0.5 |
| Soybean protein isolate | 9% | Semen Phaseoli | 4% |
| Concentrated lactoalbumin | 6% | Poria | 1% |
| Soybean protein peptide | 2% | Lentinus Edodes extract | 1% |
| Whole milk powder | 3% | Rhizoma Polygonati extract | 0.3% |
| Arginine | 1.5% | Radix Ginseng extract | 0.3% |
| Glutamine | 1.2% | Wolfberry fruit extract | 0.4% |
| Branched-chain amino acid | 2.5% | Composite mineral matter | 1.5% |
| Egg albumin polypeptide | 1.5% | Compound vitamin | 0.8% |
| Medium-chain fatty acid | 8% | Cyclic adenosine monophosphate | 700ppm |
| Omega-fatty acid | 3% | Moringa powder | 2% |
| Fructus Maydis oil | 8% |
Nutrient component meter
The hepatopathy of embodiment 3 needs full age 3# of medical usage with special
| Supplementary material title | Ratio | Supplementary material title | Ratio |
| Maltodextrin | 21% | Safflower oil | 2% |
| Enzymolysis rice flour | 15% | Oligofructose | 3% |
| Expanded corn powder | 7% | Resistant dextrin | 2% |
| Soybean protein isolate | 7% | Resistant starch | 1% |
| Concentrated lactoalbumin | 6% | Rhizomadioscoreae | 1% |
| Collagen peptide | 1% | Poria | 1% |
| Whole milk powder | 6% | Lentinus Edodes extract | 1% |
| Arginine | 1.5% | Pollen Pini | 2% |
| Glutamine | 1.2% | Seabuckthorn fruit powder | 2% |
| Branched-chain amino acid | 1% | Wolfberry fruit extract | 0.4% |
| Egg albumin polypeptide | 1% | Pericarpium Citri Reticulatae extract | 0.5 |
| Medium-chain fatty acid | 7% | Composite mineral matter | 2% |
| Omega-fatty acid | 2% | Compound vitamin | 0.8% |
| Fructus Maydis oil | 4% | Cyclic adenosine monophosphate | 300ppm |
Nutrient component meter
The hepatopathy of embodiment 4 needs full age 4# of medical usage with special
| Supplementary material title | Ratio | Supplementary material title | Ratio |
| Enzymolysis wheat flour | 30% | Fructus Lycii | 2% |
| Enzymolysis rice flour | 25% | Rhizoma Dioscoreae | 2% |
| Enzymolysis oatmeal | 10% | Radix Ginseng | 2% |
| Expanded corn powder | 10% | Fructus Hordei Germinatus | 2% |
| Collagen peptide | 1% | Lentinus Edodes extract | 1% |
| Semen Maydis oil | 1% | Thallus Laminariae (Thallus Eckloniae) | 1.9% |
| Resistant dextrin | 3% | Compound vitamin | 0.5% |
| Oligofructose | 3% | Composite mineral matter | 0.5% |
| Moringa powder | 0.1% | Cyclic adenosine monophosphate | 10ppm |
| Fructus Momordicae | 4.99% |
The hepatopathy of embodiment 5 needs full age 5# of medical usage with special
| Supplementary material title | Ratio | Supplementary material title | Ratio |
| Maltodextrin | 1% | Olive oil | 1% |
| Soybean protein peptide | 15% | Oligofructose | 12% |
| Leucine | 5% | Resistant dextrin | 8% |
| Soybean protein isolate | 4% | Resistant starch | 1% |
| Concentrated lactoalbumin | 6% | Oligochitosan | 4% |
| Collagen peptide | 4% | Poria | 1% |
| Whole milk powder | 16% | Composite mineral matter | 1% |
| Arginine | 1.5% | Compound vitamin | 1% |
| Glutamine | 1.2% | Cyclic adenosine monophosphate | 1000ppm |
| Branched-chain amino acid | 1.3% | Moringa powder | 0.99% |
| Egg albumin polypeptide | 1% | ||
| Medium-chain fatty acid | 7% | ||
| Omega-fatty acid | 2% | ||
| Soybean oil | 5% |
The hepatopathy of embodiment 6 needs full age 6# of medical usage with special
The effect of the present embodiment and effect
Clinical control experiment：
50 hepatopaths are randomly divided into into 2 groups, the nutrition of calorie [25Kcal/ (Kgd)] different product such as give
Hold scheme.
Wherein, A groups give conventional nutrient；B groups give 6.5g/ (Kgd) product 1# of the present invention (other embodiment or this
Product in the ratio range of invention)；
Respectively at nutritional intervention the last week, first week after intervening, second week, from the 3rd week and the tenth week morning extraction study right
As empty stomach peripheric venous blood, total serum protein (TP), serum albumin (ALB), hemoglobin (Hb), creatinine (Cr), urine are determined
Plain nitrogen (BUN), in the strong side upper-arm circumference (MAC) of above-mentioned several point in time measurement patients and strong side calf circumference, and recovers feelings to hepatopathy
Condition is scored.
As a result：Even if the hepatopath of A groups gives over a period to come certain nutritional support, still there is generation malnutrition
Risk and focus change it is unobvious.
Support group of the present invention is improving the aspect effects such as patient's anthropometric parameters, laboratory parameters, disease recovery
Better than matched group.
From the above it can be seen that this product nutrition it is balanced, with certain clinical effectiveness.
It follows that this product can comprehensively, in time provide the required various nutrients and trace element of hepatopath, change
Kind patient's entirety nutriture, improves immunity of organisms, reduces the generation of postoperative infection and complication；Rich in high-purity, Gao Sheng
Thing potency compound protein, improves negative nitrogen balance, effectively prevents hypoproteinemia and the multiple complications that produce；Because product is combined
The metabolic characteristic and nutritional need of hepatopath, be especially added with integration of edible and medicinal herbs living resources beneficial to hepatopath into
Point, for the malnutrition situation of hepatopath, protection hepatocyte is played, promote hepatocellular reparation and the result of regeneration, enter
And shorten length of stay, lower medical expense.
Claims (10)
1. a kind of hepatopathy needs the full age of medical usage with special, it is characterised in that by the thing of following mass percent
Matter is prepared from：
2. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
The predigestion carbohydrate is through expanded, enzymolysis processing rice meal, Semen Maydis powder, oatmeal, wheat flour, Fructus Hordei Germinatus
One or more in dextrin.
3. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
One or more of the compound protein in vegetable protein or animal proteinum；
The compound protein is by soybean protein, lactoprotein, soybean protein peptide, lact albumin hydrolysate, collagen peptide, albumin
One or more compositions in peptide, Colla Corii Asini, branched-chain amino acid, glutamine.
4. a kind of hepatopathy as claimed in claim 3 needs the full age of medical usage with special, it is characterised in that：
The branched-chain amino acid is by one or more branched-chain amino acid for constituting in leucine, isoleucine and L-Valine.
5. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
One or more of the compound fat in plant fat or Animal fat；
The compound fat preferably is selected from Fructus Maydis oil, Oleum Camelliae, safflower oil, Oleum Brassicae campestriss, olive oil, butter oil, Oleum Arachidis hypogaeae semen, Semen sojae atricolor
One or more in oil, medium-chain fatty acid and omega-fatty acid.
6. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
The dietary fiber refers to one or more in resistant starch, resistant dextrin, oligochitosan, oligofructose.
7. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
The integration of edible and medicinal herbs living resources refer to Poria, Rhizoma Polygonati, Pollen Pini, Lentinus Edodess, Radix Ginseng, Fructus Lycii, Rhizomadioscoreae, Fructus Hippophae, Pericarpium Citri Reticulatae, mountain
Medicine, Fructus Crataegi, Herba portulacae, Radix Glycyrrhizae, the Radix Angelicae Dahuricae, Semen Ginkgo, Semen Lablab Album, Semen Cassiae, Bulbus Lilii, Semen Myristicae, Cortex Cinnamomi, Fructus Phyllanthi, Semen Euryaless, wheat
Bud, Thallus Laminariae (Thallus Eckloniae), Fructus Momordicae, Semen Pruni, Flos Lonicerae Fructus Canarii, Herba Houttuyniae, Semen Hoveniae (Fructus Hoveniae), Fructus Gardeniae, Fructus Amomi, Fructus Citri, Herba Moslae, Semen Persicae, Fructus Alpiniae Oxyphyllae
Core, Folium Nelumbinis, Semen Nelumbinis, Semen Sinapiss, Folium Perillae, Radix Puerariae, Herba Taraxaci, Semen Ziziphi Spinosae, Herba Menthae, Semen Coiciss, Fructus Rubi, coriander, Flos Lonicerae, cloth
Slag leaf, Spica Prunellae, Stigma Croci, Fructus Tsaoko, Rhizoma Kaempferiae etc. one or more；
Preferably, the integration of edible and medicinal herbs living resources include Poria, Rhizoma Polygonati, Pollen Pini, Lentinus Edodess, Radix Ginseng, Fructus Lycii, Rhizomadioscoreae, sand
At least one component in spine, Pericarpium Citri Reticulatae.
8. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：
Described mineral substance premix is selected from containing the one kind in sodium, potassium, calcium, phosphorus, magnesium, ferrum, iodine, copper, zinc, manganese, selenium, molybdenum, chromium
Or the premix material of several mineral elements.
9. a kind of hepatopathy as claimed in claim 1 needs the full age of medical usage with special, it is characterised in that：It is described
Vitamin premix selected from vitamin A, vitamin D, Vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B6,
One or more in Vitamin B12, vitamin C, nicotinic acid, Folic Acid, pantothenic acid, biotin, choline, taurine.
10. a kind of hepatopathy as described in claim 1-9 is arbitrary needs the full age of medical usage, its feature to exist with special
In being prepared from by the material of following mass percent：
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610371259.6A CN106605908A (en) | 2016-05-27 | 2016-05-27 | Fully nutritional formula product with special medical purposes for liver diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610371259.6A CN106605908A (en) | 2016-05-27 | 2016-05-27 | Fully nutritional formula product with special medical purposes for liver diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106605908A true CN106605908A (en) | 2017-05-03 |
Family
ID=58614667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610371259.6A Pending CN106605908A (en) | 2016-05-27 | 2016-05-27 | Fully nutritional formula product with special medical purposes for liver diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106605908A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107125387A (en) * | 2017-05-16 | 2017-09-05 | 广西习缘辣木有限公司 | A kind of preparation method of selenium-rich Moringa tea |
| CN107173794A (en) * | 2017-06-12 | 2017-09-19 | 金梅 | A kind of alimentation composition for promoting patients with severe head injury to recover and its application |
| CN107510044A (en) * | 2017-09-09 | 2017-12-26 | 李绍波 | A kind of clinical liver disease nutrient formulation and preparation method thereof |
| CN108077912A (en) * | 2017-12-25 | 2018-05-29 | 陕西三正医用营养有限公司 | A kind of full nutrition special medicine purposes formula food and preparation method thereof |
| CN108283314A (en) * | 2017-11-30 | 2018-07-17 | 新疆阜丰生物科技有限公司 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
| CN108434274A (en) * | 2018-05-14 | 2018-08-24 | 蒋志秉 | A kind of Chinese medicine composition for protect liver |
| CN108991500A (en) * | 2018-07-02 | 2018-12-14 | 邦世迪(广东)医用食品股份有限公司 | A kind of tumour patient full nutrition formula food |
| CN109123642A (en) * | 2018-09-27 | 2019-01-04 | 蔡勤 | With the integration of drinking and medicinal herbs food of zero injury repair gene therapy cancer |
| CN109430884A (en) * | 2018-11-26 | 2019-03-08 | 荣海生物科技有限公司 | A variety of biological nutritive agents of small-molecular peptides and preparation method thereof |
| CN110122863A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof improving liver function |
| CN110200273A (en) * | 2019-06-06 | 2019-09-06 | 王仲 | A kind of clinical liver disease nutritious food and preparation method thereof |
| CN110447892A (en) * | 2019-07-24 | 2019-11-15 | 北京诺康达医药科技股份有限公司 | A kind of special medicine purposes amino acid pattern hepatopathy full nutrition formula food |
| CN110604315A (en) * | 2019-10-12 | 2019-12-24 | 襄阳市世诠生物科技有限公司 | Composition for meeting nutritional requirements of hepatopaths and preparation method thereof |
| CN110973611A (en) * | 2019-12-27 | 2020-04-10 | 湖南生命元医药有限责任公司 | Special medical application formula food for hepatitis patients and preparation method thereof |
| CN111227235A (en) * | 2020-03-05 | 2020-06-05 | 北京诺康达医药科技股份有限公司 | Total-nutrient formula food for liver diseases and preparation method and application thereof |
| CN111329044A (en) * | 2020-02-24 | 2020-06-26 | 杭州泽健医药科技有限公司 | Composition for recovering patients with liver diseases |
| CN113841889A (en) * | 2021-08-10 | 2021-12-28 | 许昌学院 | Cell absorption combined functional nutrient |
| CN114343172A (en) * | 2022-01-28 | 2022-04-15 | 特康药业集团有限公司 | Application of traditional Chinese medicine composition in food for improving liver function of chronic liver disease patient, nutrition powder and preparation method |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102246967A (en) * | 2011-05-25 | 2011-11-23 | 广州邦世迪生物技术有限公司 | Normal full nutrient |
| CN102771797A (en) * | 2012-07-24 | 2012-11-14 | ***广州总医院 | All-round enteral nutrition preparation and preparation method thereof |
| CN104223057A (en) * | 2014-07-24 | 2014-12-24 | 胡安然 | Total-nutrient formula food for hepatopath |
| CN104824655A (en) * | 2015-05-26 | 2015-08-12 | 南阳市汇博生物技术有限公司 | Basic full-nutritional special medical formula food and preparation technique thereof |
| CN104839656A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Liver disease medicine formula food |
| CN104920967A (en) * | 2015-05-28 | 2015-09-23 | 北京康百世科技发展有限公司 | Nutritional supplement with effects of relieving alcoholism and protecting livers, and preparation method of nutritional supplement |
| CN105361146A (en) * | 2015-11-09 | 2016-03-02 | 劲膳美生物科技股份有限公司 | Total-nutrient special formula food edible by hepatosis patients |
| CN105558046A (en) * | 2016-01-12 | 2016-05-11 | 刘保惠 | Formula food with special medicinal purpose and suitable for liver disease and preparation method thereof |
-
2016
- 2016-05-27 CN CN201610371259.6A patent/CN106605908A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102246967A (en) * | 2011-05-25 | 2011-11-23 | 广州邦世迪生物技术有限公司 | Normal full nutrient |
| CN102771797A (en) * | 2012-07-24 | 2012-11-14 | ***广州总医院 | All-round enteral nutrition preparation and preparation method thereof |
| CN104223057A (en) * | 2014-07-24 | 2014-12-24 | 胡安然 | Total-nutrient formula food for hepatopath |
| CN104839656A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Liver disease medicine formula food |
| CN104824655A (en) * | 2015-05-26 | 2015-08-12 | 南阳市汇博生物技术有限公司 | Basic full-nutritional special medical formula food and preparation technique thereof |
| CN104920967A (en) * | 2015-05-28 | 2015-09-23 | 北京康百世科技发展有限公司 | Nutritional supplement with effects of relieving alcoholism and protecting livers, and preparation method of nutritional supplement |
| CN105361146A (en) * | 2015-11-09 | 2016-03-02 | 劲膳美生物科技股份有限公司 | Total-nutrient special formula food edible by hepatosis patients |
| CN105558046A (en) * | 2016-01-12 | 2016-05-11 | 刘保惠 | Formula food with special medicinal purpose and suitable for liver disease and preparation method thereof |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107125387A (en) * | 2017-05-16 | 2017-09-05 | 广西习缘辣木有限公司 | A kind of preparation method of selenium-rich Moringa tea |
| CN107125387B (en) * | 2017-05-16 | 2021-04-27 | 广西习缘辣木有限公司 | Preparation method of selenium-rich moringa oleifera tea |
| CN107173794A (en) * | 2017-06-12 | 2017-09-19 | 金梅 | A kind of alimentation composition for promoting patients with severe head injury to recover and its application |
| CN107510044A (en) * | 2017-09-09 | 2017-12-26 | 李绍波 | A kind of clinical liver disease nutrient formulation and preparation method thereof |
| CN108283314A (en) * | 2017-11-30 | 2018-07-17 | 新疆阜丰生物科技有限公司 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
| CN108077912A (en) * | 2017-12-25 | 2018-05-29 | 陕西三正医用营养有限公司 | A kind of full nutrition special medicine purposes formula food and preparation method thereof |
| CN108434274B (en) * | 2018-05-14 | 2021-01-08 | 蒋志秉 | Traditional Chinese medicine composition for protecting liver |
| CN108434274A (en) * | 2018-05-14 | 2018-08-24 | 蒋志秉 | A kind of Chinese medicine composition for protect liver |
| CN108991500A (en) * | 2018-07-02 | 2018-12-14 | 邦世迪(广东)医用食品股份有限公司 | A kind of tumour patient full nutrition formula food |
| CN109123642A (en) * | 2018-09-27 | 2019-01-04 | 蔡勤 | With the integration of drinking and medicinal herbs food of zero injury repair gene therapy cancer |
| CN109430884A (en) * | 2018-11-26 | 2019-03-08 | 荣海生物科技有限公司 | A variety of biological nutritive agents of small-molecular peptides and preparation method thereof |
| CN110122863A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof improving liver function |
| CN110200273A (en) * | 2019-06-06 | 2019-09-06 | 王仲 | A kind of clinical liver disease nutritious food and preparation method thereof |
| CN110447892A (en) * | 2019-07-24 | 2019-11-15 | 北京诺康达医药科技股份有限公司 | A kind of special medicine purposes amino acid pattern hepatopathy full nutrition formula food |
| CN110604315A (en) * | 2019-10-12 | 2019-12-24 | 襄阳市世诠生物科技有限公司 | Composition for meeting nutritional requirements of hepatopaths and preparation method thereof |
| CN110973611A (en) * | 2019-12-27 | 2020-04-10 | 湖南生命元医药有限责任公司 | Special medical application formula food for hepatitis patients and preparation method thereof |
| CN111329044A (en) * | 2020-02-24 | 2020-06-26 | 杭州泽健医药科技有限公司 | Composition for recovering patients with liver diseases |
| CN111227235A (en) * | 2020-03-05 | 2020-06-05 | 北京诺康达医药科技股份有限公司 | Total-nutrient formula food for liver diseases and preparation method and application thereof |
| CN111227235B (en) * | 2020-03-05 | 2022-09-02 | 北京诺葆营养科技有限公司 | Total-nutrient formula food for liver diseases and preparation method and application thereof |
| CN113841889A (en) * | 2021-08-10 | 2021-12-28 | 许昌学院 | Cell absorption combined functional nutrient |
| WO2023015756A1 (en) * | 2021-08-10 | 2023-02-16 | 河南科谱特医药科技研究院有限公司 | Combined functional nutrient for cell absorption |
| CN114343172A (en) * | 2022-01-28 | 2022-04-15 | 特康药业集团有限公司 | Application of traditional Chinese medicine composition in food for improving liver function of chronic liver disease patient, nutrition powder and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106605908A (en) | Fully nutritional formula product with special medical purposes for liver diseases | |
| CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
| CN102805266B (en) | Feed for improving digestive and immunologic ability of chicken | |
| CN102342418A (en) | Food composition with functions of tonifying spleen and nourishing stomach and preparation method thereof | |
| CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
| CN106174585A (en) | Hypoglycemic compositions and hypoglycemic compound probiotic spy's dietary seafood | |
| CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
| CN105029407A (en) | Medical formula food for inflammatory bowel disease | |
| CN104082658A (en) | Instant food for lowering high blood sugar, high blood pressure and high blood lipids and strengthening yang | |
| CN104855985A (en) | Non-complete-nutrition formula food for high uric acid | |
| CN104839707A (en) | Yin deficiency physique non-total nutrient formula food | |
| CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
| CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
| CN104855975A (en) | Non-total-nutrient formula food for sarcopenia syndrome | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN102197837A (en) | Sea buckthorn fiber biscuits | |
| CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
| CN105326038A (en) | Pregnant-woman pregnancy-vomiting total-nutrient formula food | |
| CN104996992A (en) | Medical formula food for muscle attenuation syndromes | |
| CN104856000A (en) | Non-complete-nutrition formula food for insomnia | |
| CN104824674A (en) | Nutrient health-care food for preventing and treating alopecia | |
| CN104839678A (en) | Medical formula food for people with nephrosis | |
| CN104839698A (en) | Cardiovascular disease non-total nutrient formula food | |
| CN104872646A (en) | Non-full-nutrition formula food for patients with colorectal cancers | |
| CN104855970A (en) | Non-whole nutrient formula food for hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information |
Address after: 512000 Guangdong province Shaoguan Zhenjiang Zhenjiang Li Shi Zhen Industrial Park Industrial Road No. 8 Applicant after: United Kingdom (Guangdong) medical food Limited by Share Ltd Address before: 512000 Guangdong province Shaoguan Zhenjiang Zhenjiang Li Shi Zhen Industrial Park Industrial Road No. 8 Applicant before: SHAOGUAN BANGSHIDI HEALTH INDUSTRY CO., LTD. |
|
| CB02 | Change of applicant information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |